Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Thiazolylimidazole derivatives and their use as inhibitors of microsomal triglyceride transfer protein

Thiazolylimidazole derivatives and their use as inhibitors of microsomal triglyceride transfer protein

US Patent 7767819 · Granted Aug 3, 2010

Estimated economic value: $49,103,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

O-alkyl-benzylideneguanidine derivatives and therapeutic use for the treatment o2021
Benzylideneguanidine derivatives and therapeutic use for the treatment of protei2021
Therapeutic uses of benzylideneguanidine derivatives for the treatment of proteo2020
Method of treating cancer with a combination of benzylideneguanidine derivatives2020
O-alkyl-benzylideneguanidine derivatives and therapeutic use for the treatment o2020
Benzylideneguanidine derivatives and therapeutic use for the treatment of protei2020
Benzylideneguanidine derivatives and therapeutic use for the treatment of protei2018
Benzylideneguanidine derivatives and therapeutic use for the treatment of protei2017
Macrocyclic serine protease inhibitors, pharmaceutical compositions thereof, and2016
Macrocyclic serine protease inhibitors2016
5,5-fused arylene or heteroarylene hepatitis C virus inhibitors2015
Macrocyclic serine protease inhibitors2015